secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRX Pharmaceuticals, Inc. (NRXP)
CIK:        0001719406
Form:       8-K
Filed at:   2024-03-21T23:59:59+00:00
Accession:  0001104659-24-037389
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NRx Pharmaceuticals shareholders approve reverse stock split proposal with 94.4% support
--------------------------------------------------------------------------------

- 94.4% (53,597,974) of votes cast at March 21, 2024 special meeting favor reverse split.
- Board authorized to effect split at ratio of 1-for-2 to 1-for-15 within one year.
- 61.4% (56,781,354) of eligible shares voted despite internet campaign to suppress vote.
- Company expects to share annual report on March 28 and update investors on progress.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1719406/000110465924037389/0001104659-24-037389-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1719406/000110465924037389/tm2333863d6_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-037389

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer